Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Diagnosis of lung cancer depends on lung histology or sputum shedding cytology. Screening methods for lung cancer mainly include X-ray chest X-ray and sputum cytology, low-dose spiral CT, blood and sputum biomarkers, and exhalation gas monitoring.
As people's awareness of cancer increases and technology advances, as well as private and government support, these are some of the factors that are expected to drive market growth.
The report details the trend, potential and market size of Lung Cancer Diagnostics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Lung Cancer Diagnosticsmarket, defines the market attractiveness level of Lung Cancer Diagnostics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Lung Cancer Diagnostics industry, describes the types of Lung Cancer Diagnostics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Lung Cancer Diagnostics market and the development prospects and opportunities of Lung Cancer Diagnostics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Lung Cancer Diagnostics market in Chapter 13.
By Player:
Thermo Fisher Scientific
Agilent Technologies
Illumina Inc
AstraZeneca plc
Sanofi SA
Janssen
Qiagen NV
Roche Diagnostics
bioMérieux
By Type:
Biopsy
Imaging Test
Molecular Test
Sputum Cytology
Others
By End-User:
Hospital
Clinic
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Lung Cancer Diagnostics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Lung Cancer Diagnostics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Lung Cancer Diagnostics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Lung Cancer Diagnostics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Lung Cancer Diagnostics Market Analysis and Outlook to 2022
-
7.1 Global Lung Cancer Diagnostics Consumption (2017-2022)
-
7.2 United States Lung Cancer Diagnostics Consumption (2017-2022)
-
7.3 Europe Lung Cancer Diagnostics Consumption (2017-2022)
-
7.4 China Lung Cancer Diagnostics Consumption (2017-2022)
-
7.5 Japan Lung Cancer Diagnostics Consumption (2017-2022)
-
7.6 India Lung Cancer Diagnostics Consumption (2017-2022)
-
7.7 South Korea Lung Cancer Diagnostics Consumption (2017-2022)
8 Region and Country-wise Lung Cancer Diagnostics Market Analysis and Outlook to 2028
-
8.1 Global Lung Cancer Diagnostics Consumption Forecast (2022-2028)
-
8.2 United States Lung Cancer Diagnostics Consumption Forecast (2022-2028)
-
8.3 Europe Lung Cancer Diagnostics Consumption Forecast (2022-2028)
-
8.4 China Lung Cancer Diagnostics Consumption Forecast (2022-2028)
-
8.5 Japan Lung Cancer Diagnostics Consumption Forecast (2022-2028)
-
8.6 India Lung Cancer Diagnostics Consumption Forecast (2022-2028)
-
8.7 South Korea Lung Cancer Diagnostics Consumption Forecast (2022-2028)
9 Global Lung Cancer Diagnostics Market Outlook by Types and Applications to 2022
-
9.1 Global Lung Cancer Diagnostics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Biopsy Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Imaging Test Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Molecular Test Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Sputum Cytology Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Lung Cancer Diagnostics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Lung Cancer Diagnostics Market Outlook by Types and Applications to 2028
-
10.1 Global Lung Cancer Diagnostics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Biopsy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Imaging Test Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Molecular Test Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Sputum Cytology Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Lung Cancer Diagnostics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Lung Cancer Diagnostics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Lung Cancer Diagnostics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Lung Cancer Diagnostics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Lung Cancer Diagnostics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Lung Cancer Diagnostics Market Competitive Analysis
-
14.1 Thermo Fisher Scientific
-
14.1.1 Thermo Fisher Scientific Company Details
-
14.1.2 Thermo Fisher Scientific Lung Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Thermo Fisher Scientific Lung Cancer Diagnostics Product and Service
-
14.2 Agilent Technologies
-
14.2.1 Agilent Technologies Company Details
-
14.2.2 Agilent Technologies Lung Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Agilent Technologies Lung Cancer Diagnostics Product and Service
-
14.3 Illumina Inc
-
14.3.1 Illumina Inc Company Details
-
14.3.2 Illumina Inc Lung Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Illumina Inc Lung Cancer Diagnostics Product and Service
-
14.4 AstraZeneca plc
-
14.4.1 AstraZeneca plc Company Details
-
14.4.2 AstraZeneca plc Lung Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 AstraZeneca plc Lung Cancer Diagnostics Product and Service
-
14.5 Sanofi SA
-
14.5.1 Sanofi SA Company Details
-
14.5.2 Sanofi SA Lung Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Sanofi SA Lung Cancer Diagnostics Product and Service
-
14.6 Janssen
-
14.6.1 Janssen Company Details
-
14.6.2 Janssen Lung Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Janssen Lung Cancer Diagnostics Product and Service
-
14.7 Qiagen NV
-
14.7.1 Qiagen NV Company Details
-
14.7.2 Qiagen NV Lung Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Qiagen NV Lung Cancer Diagnostics Product and Service
-
14.8 Roche Diagnostics
-
14.8.1 Roche Diagnostics Company Details
-
14.8.2 Roche Diagnostics Lung Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Roche Diagnostics Lung Cancer Diagnostics Product and Service
-
14.9 bioMérieux
-
14.9.1 bioMérieux Company Details
-
14.9.2 bioMérieux Lung Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 bioMérieux Lung Cancer Diagnostics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Lung Cancer Diagnostics
-
Figure Lung Cancer Diagnostics Picture
-
Table Global Lung Cancer Diagnostics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Lung Cancer Diagnostics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Lung Cancer Diagnostics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Lung Cancer Diagnostics Consumption by Country (2017-2022)
-
Figure United States Lung Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Table Europe Lung Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure China Lung Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Japan Lung Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure India Lung Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Lung Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Global Lung Cancer Diagnostics Consumption Forecast by Country (2022-2028)
-
Figure United States Lung Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Lung Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Lung Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Lung Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Lung Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Lung Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Biopsy Consumption and Growth Rate (2017-2022)
-
Figure Global Imaging Test Consumption and Growth Rate (2017-2022)
-
Figure Global Molecular Test Consumption and Growth Rate (2017-2022)
-
Figure Global Sputum Cytology Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Biopsy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Imaging Test Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Molecular Test Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Sputum Cytology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Lung Cancer Diagnostics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Lung Cancer Diagnostics Export by Region (Top 5 Countries) (2017-2028)
-
Table Thermo Fisher Scientific (Foundation Year, Company Profile and etc.)
-
Table Thermo Fisher Scientific Lung Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Thermo Fisher Scientific Lung Cancer Diagnostics Product and Service
-
Table Agilent Technologies (Foundation Year, Company Profile and etc.)
-
Table Agilent Technologies Lung Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Agilent Technologies Lung Cancer Diagnostics Product and Service
-
Table Illumina Inc (Foundation Year, Company Profile and etc.)
-
Table Illumina Inc Lung Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Illumina Inc Lung Cancer Diagnostics Product and Service
-
Table AstraZeneca plc (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca plc Lung Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca plc Lung Cancer Diagnostics Product and Service
-
Table Sanofi SA (Foundation Year, Company Profile and etc.)
-
Table Sanofi SA Lung Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi SA Lung Cancer Diagnostics Product and Service
-
Table Janssen (Foundation Year, Company Profile and etc.)
-
Table Janssen Lung Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Janssen Lung Cancer Diagnostics Product and Service
-
Table Qiagen NV (Foundation Year, Company Profile and etc.)
-
Table Qiagen NV Lung Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Qiagen NV Lung Cancer Diagnostics Product and Service
-
Table Roche Diagnostics (Foundation Year, Company Profile and etc.)
-
Table Roche Diagnostics Lung Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Diagnostics Lung Cancer Diagnostics Product and Service
-
Table bioMérieux (Foundation Year, Company Profile and etc.)
-
Table bioMérieux Lung Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table bioMérieux Lung Cancer Diagnostics Product and Service
-
